Document is current
Any future updates will be listed below
-
Authors
White, Cassandra
Wardill, Hannah
Paul, Christine
Price, Timothy
Karapetis, Christos
Nalder, Mark
Burge, Matthew E.
Thomas, Ann
Oldmeadow, Chris
Barker, Daniel
Edney, Laura C.
Coller, Janet
Bowen, Joanne
Ostroff, Cheri
Cheek, Bruce
Carlson, Mel
Rankmore, Trumaine
Nagrial, Adnan
Clarke, Stephen
Chantrill, Lorraine
Ackland, Stephen
Scott, Rodney J.
- License Information
-
More Information
Article History
Received: 3 September 2024
Accepted: 28 October 2024
First Online: 8 November 2024
Declarations
:
: Ethics approval was obtained from Hunter New England Human Research Ethics Committee (2023/ETH01211, 17th August 2023) and University of Newcastle Research Integrity Unit (R-2024–0032, 25th June 2024). This trial was registered with the Australian and New Zealand Cancer Trials Registry on 13th Dec 2023, ACTRN12623001301651. Written informed consent will be signed and dated by both the participating patient and investigator or delegates prior to any study-related activity being undertaken (Supp Fig. 2). An option for electronic consent will be available at participating centres. Patients will be given the option of being contacted for patient interview. Current protocol version is 3.2, August 2024.
: Not applicable.
: The authors declare no competing interests.
